Nenad Sarapa

1.8k total citations
48 papers, 1.4k citations indexed

About

Nenad Sarapa is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Nenad Sarapa has authored 48 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Nenad Sarapa's work include Cardiac electrophysiology and arrhythmias (22 papers), ECG Monitoring and Analysis (16 papers) and Ion channel regulation and function (6 papers). Nenad Sarapa is often cited by papers focused on Cardiac electrophysiology and arrhythmias (22 papers), ECG Monitoring and Analysis (16 papers) and Ion channel regulation and function (6 papers). Nenad Sarapa collaborates with scholars based in United States, Switzerland and United Kingdom. Nenad Sarapa's co-authors include Fabio Badilini, Börje Darpö, Christine Garnett, Wojciech Zaręba, Steve Riley, James J. Keirns, Charles Benson, Manish Gupta, René Bruno and Jing He and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Nenad Sarapa

48 papers receiving 1.3k citations

Peers

Countries citing papers authored by Nenad Sarapa

Since Specialization

Citations

This map shows the geographic impact of Nenad Sarapa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nenad Sarapa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nenad Sarapa more than expected).

Fields of papers citing papers by Nenad Sarapa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nenad Sarapa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nenad Sarapa. The network helps show where Nenad Sarapa may publish in the future.

Co-authorship network of co-authors of Nenad Sarapa

This figure shows the co-authorship network connecting the top 25 collaborators of Nenad Sarapa. A scholar is included among the top collaborators of Nenad Sarapa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nenad Sarapa. Nenad Sarapa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Novel Antibody Therapeutics Targeting Mesothelin In Solid Tumors 2016 ·PubMed ·Xiaoyan Zhao, Babu Subramanyam, Nenad Sarapa, Sven Golfier, Harald Dinter	41
2	Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors 2015 ·Cancer Chemotherapy and Pharmacology ·Amita Patnaik, Anthony W. Tolcher, M. Beeram, John Nemunaitis, Glen J. Weiss, Kapil N. Bhalla, Manish Agrawal, Gwen Nichols, Steven A. Middleton, (unknown), Nenad Sarapa, Richard Peck, Jianguo Zhi	37
3	Effect of axitinib on the QT interval in healthy volunteers 2015 ·Cancer Chemotherapy and Pharmacology ·Ana Ruiz-Garcı́a, Brett E. Houk, Yazdi K. Pithavala, Melvin Toh, Nenad Sarapa, Michael A. Tortorici	9
4	Prediction of overall survival or progression free survival by disease control rate at week 8 is independent of ethnicity: Western versus Chinese patients with first‐line non‐small cell lung cancer treated with chemotherapy with or without bevacizumab 2013 ·The Journal of Clinical Pharmacology ·Laurent Claret, Manish Gupta, Kelong Han, Amita Joshi, Nenad Sarapa, Jing He, (unknown), René Bruno	17
5	A phase I, randomized, open-label study of the multiple-dose pharmacokinetics of vemurafenib in patients with BRAF V600E mutation-positive metastatic melanoma 2013 ·Cancer Chemotherapy and Pharmacology ·Joseph F. Grippo, (unknown), Dominik Heinzmann, (unknown), James R. Wong, Andrew K. Joe, Pamela N. Münster, Nenad Sarapa, Adil Daud	36
6	Effect of ketoconazole on the pharmacokinetics of axitinib in healthy volunteers 2010 ·Investigational New Drugs ·Yazdi K. Pithavala, (unknown), (unknown), Sadayappan V. Rahavendran, May Garrett, Brian Hee, Paulina Selaru, Nenad Sarapa, Karen J. Klamerus	53
7	Comparison of QTinno, a fully automated electrocardiographic analysis program, to semiautomated electrocardiographic analysis methods in a drug safety study in healthy subjects 2009 ·Journal of Electrocardiology ·Nenad Sarapa, Ihor Gussak, (unknown), (unknown), Ljupčo Hadžievski, Steven F. Francom, Peter R. Kowey	12
8	Automatic analysis of cardiac repolarization morphology using Gaussian mesa function modeling 2008 ·Journal of Electrocardiology ·Fabio Badilini, Martino Vaglio, Rémi Dubois, Pierre Roussel, Nenad Sarapa, Isabelle Denjoy, Fabrice Extramiana, Pierre Maison‐Blanche	14
9	Quantitative Performance of E‐Scribe Warehouse in Detecting Quality Issues With Digital Annotated ECG Data From Healthy Subjects 2008 ·The Journal of Clinical Pharmacology ·Nenad Sarapa, (unknown), (unknown), (unknown), Fabio Badilini	8
10	Investigating the effect of sotalol on the repolarization intervals in healthy young individuals 2008 ·Journal of Electrocardiology ·Jean‐Philippe Couderc, Meijian Zhou, Nenad Sarapa, Wojciech Zaręba	16
11	Impaired T‐Amplitude Adaptation to Heart Rate Characterizes I_Kr Inhibition in the Congenital and Acquired Forms of the Long QT Syndrome 2007 ·Journal of Cardiovascular Electrophysiology ·Jean‐Philippe Couderc, Martino Vaglio, (unknown), Scott McNitt, Pierre Wicker, Nenad Sarapa, Arthur J. Moss, Wojciech Zaręba	37
12	Quality assessment of digital annotated ECG data from clinical trials by the FDA ECG warehouse 2007 ·Expert Opinion on Drug Safety ·Nenad Sarapa	5
13	Ritonavir 100 mg Does Not Cause QTc Prolongation in Healthy Subjects: A Possible Role as CYP3A Inhibitor in Thorough QTc Studies 2007 ·Clinical Pharmacology & Therapeutics ·Nenad Sarapa, Dana J. Nickens, Susan Raber, (unknown), Michael Amantea	29
14	Exploratory IND: A New Regulatory Strategy for Early Clinical Drug Development in the United States 2007 ·PubMed ·Nenad Sarapa	4
15	Analyses of Dynamic Beat‐to‐Beat QT–TQ Interval (ECG Restitution) Changes in Humans under Normal Sinus Rhythm and Prior to an Event of Torsades de Pointes during QT Prolongation Caused by Sotalol 2007 ·Annals of Noninvasive Electrocardiology ·Anthony A. Fossa, Todd Wisialowski, Kimberly Crimin, (unknown), Jean‐Philippe Couderc, Martin Hinterseer, Stefan Kääb, Wojciech Zareba, Fabio Badilini, Nenad Sarapa	32
16	Implications of methodological differences in digital electrocardiogram interval measurement 2006 ·Journal of Electrocardiology ·Fabio Badilini, Nenad Sarapa	32
17	The effect of mild and moderate hepatic impairment on the pharmacokinetics of valdecoxib, a selective COX-2 inhibitor 2005 ·European Journal of Clinical Pharmacology ·Nenad Sarapa, (unknown), (unknown), Kourosh Parivar	7
18	Valdecoxib, a COX‐2‐Specific Inhibitor, Does Not Affect Cardiac Repolarization 2003 ·The Journal of Clinical Pharmacology ·Nenad Sarapa, (unknown), (unknown), Steven R. Cox, Steven F. Francom, Na Jin, (unknown), Stephen M. Sainati, (unknown), Joseph C. Fleishaker	2
19	Pharmacokinetics of intravenously administered digoxin in patients with edema 1995 ·Acta Pharmaceutica ·(unknown), (unknown), (unknown), Mirjana Huić, (unknown), Igor Francetić, (unknown), Nenad Sarapa	1
20	Pharmacokinetic Changes in Patients With Oedema 1995 ·Clinical Pharmacokinetics ·(unknown), Nenad Sarapa, (unknown), Mirjana Huić, (unknown), Igor Francetić, (unknown), (unknown)	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact